EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Advances and Strategies in Enhancing mRNA Cancer Vaccines

Miao Zhang, Shengqi Chen, Haijun Hu, Yenhui Ong, Qianqian Ni iD

Advanced Materials · 2025-10 · 37 (42)

DOI: 10.1002/adma.202509880 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Materials, online erschienen am 07.08.2025. Verfasst von Miao Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. Hauptthemen laut MEDLINE: Cancer Vaccines, RNA, Messenger, Neoplasms, mRNA Vaccines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 315 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National University of Singapore, NUS School of Medicine Nanomedicine Translational Research Programme, Overseas Visiting and Training Projects for Top Talents of Colleges and Universities of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Messenger RNA (mRNA) vaccine has emerged as a promising strategy in cancer immunotherapy, enabling the induction of precise and robust immune responses against tumor antigens. Nevertheless, enormous challenges remain, in particular its limitations in achieving optimal immunogenicity and therapeutic efficacy, result in modest clinical benefit. Here, the biological barriers are reviewed that impede the functionality of mRNA cancer vaccine and describe the design considerations, including structure engineering, chemical modification, and development of next‐generation delivery materials for enhancing cancer immunotherapy. Recent advances are highlighted aimed at improving vaccine efficacy through targeted delivery, modulation of immune cell interactions, and stimulation of innate immune responses. Finally, the challenges are examined in clinical translation and explore future directions for improving the therapeutic potential of mRNA cancer vaccines. By synthesizing current progress and identifying critical hurdles, this review provides a framework for advancing mRNA‐based cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesRNA, MessengerNeoplasmsmRNA VaccinesHumansImmunotherapyAnimals

Stichwörter der Autor:innen

adjuvantscancer vaccinedeliveryimmunotherapymRNA

Substanzen

Cancer VaccinesRNA, MessengermRNA Vaccines

Autor:innen und Institutionen

  • Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore.
  • Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117597, Singapore.
  • Key Laboratory of Xin'an Medicine, the Ministry of Education, Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application, Anhui University of Chinese Medicine, Hefei, Anhui, 230038, China.
  • WeiFang People's Hospital, Shandong Second Medical University, WeiFang, Shandong, 261000, China.

ORCID-Profile: Qianqian Ni

Förderung

  • National University of Singapore
  • NUS School of Medicine Nanomedicine Translational Research Programme
  • Overseas Visiting and Training Projects for Top Talents of Colleges and Universities of Anhui Province
  • Agency for Science, Technology and Research
  • Ministry of Education - Singapore
  • National Medical Research Council
  • National Research Foundation (NRF) Competitive Research Program

Zitieren

APA

Zhang, M., Chen, S., Hu, H., Ong, Y., & Ni, Q. (2025). Advances and Strategies in Enhancing mRNA Cancer Vaccines. Advanced Materials, 37(42). https://doi.org/10.1002/adma.202509880

Vancouver

Zhang M, Chen S, Hu H, Ong Y, Ni Q. Advances and Strategies in Enhancing mRNA Cancer Vaccines. Advanced Materials. 2025;37(42). doi:10.1002/adma.202509880

BibTeX
@article{Zhang2025,
  author = {Zhang, Miao and Chen, Shengqi and Hu, Haijun and Ong, Yenhui and Ni, Qianqian},
  title = {Advances and Strategies in Enhancing mRNA Cancer Vaccines},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {42},
  doi = {10.1002/adma.202509880}
}
Kostenlos starten →